Literature DB >> 13851885

Raynaud's disease, Raynaud's phenomenon, and serotonin.

A HALPERN, P H KUHN, H E SHAFTEL, S S SAMUELS, N SHAFTEL, D SELMAN, H G BRICH.   

Abstract

Entities:  

Keywords:  RAYNAUD'S DISEASE; SEROTONIN

Mesh:

Substances:

Year:  1960        PMID: 13851885     DOI: 10.1177/000331976001100301

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


× No keyword cloud information.
  17 in total

Review 1.  Pathogenesis and treatment of Raynaud's phenomenon.

Authors:  J D Coffman
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

2.  Effects of intra-arterial ketanserin in Raynaud's phenomenon assessed by 99MTc-pertechnetate scintigraphy.

Authors:  J J Kunnen; H P Dahler; J G Doorenspleet; J C van Oene
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon.

Authors:  I A Reilly; L Roy; G A Fitzgerald
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-19

4.  Ketanserin treatment and serotonin in patients with primary and secondary Raynaud's phenomenon.

Authors:  B Marasini; M L Biondi; E Bianchi; P Dell'Orto; A Agostoni
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  Biofeedback in the treatment of vasoconstrictive syndromes.

Authors:  E Taub; C F Stroebel
Journal:  Biofeedback Self Regul       Date:  1978-12

6.  Treatment of Raynaud's phenomenon with ketanserin in patients with connective tissue disorders.

Authors:  O K Roald; E Seem
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-08

7.  Pathophysiology of Raynaud's phenomenon.

Authors: 
Journal:  Br Med J       Date:  1980-10-18

8.  Dissipation mechanisms for 5-hydroxytryptamine in the coronary circulation of the isolated perfused heart of the rat.

Authors:  L J Bryan; S R O'Donnell; A M Williams
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

9.  Cold-induced Raynaud's phenomenon ameliorated by intravenous administration of ketanserin: a double-blind cross-over study.

Authors:  H Baart de la Faille; H van Weelden; J D Banga; R G van Kesteren
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

Review 10.  Serotonin and the vascular system. Role in health and disease, and implications for therapy.

Authors:  D S Houston; P M Vanhoutte
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.